More articles from Review

  • Evaluation and management of premature ventricular complexes
    Evaluation and management of premature ventricular complexes
    Daniel J. Cantillon, MD
    Cleveland Clinic Journal of Medicine June 2013, 80 (6) 377-387; DOI: https://doi.org/10.3949/ccjm.80a.12168

    The diagnostic evaluation should include an assessment for structural heart disease and ambulatory Holter monitoring.

  • Preserving fertility in female cancer patients: A snapshot of the options
    Ilaria Soave, MD, Giuseppe Lo Monte, MD, Emilio Giugliano, MD, Angela Graziano, MD and Roberto Marci, PhD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 309-317; DOI: https://doi.org/10.3949/ccjm.80a.12065

    With the odds of surviving cancer improving, many young women facing therapy may first wish to take steps to ensure that they will still be able to bear children afterward.

  • Recognizing and managing hereditary angioedema
    Recognizing and managing hereditary angioedema
    Kevin Tse, MD and Bruce L. Zuraw, MD
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 297-308; DOI: https://doi.org/10.3949/ccjm.80a.12073

    Recognizing this rare but life-threatening disease is crucial, especially now that drugs are available to prevent and treat acute attacks.

  • Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events
    Ki Park, MD and Anthony A. Bavry, MD, MPH
    Cleveland Clinic Journal of Medicine May 2013, 80 (5) 318-326; DOI: https://doi.org/10.3949/ccjm.80a.12146

    Aspirin’s benefits in primary prevention are not as clear as in secondary prevention, particularly in people with diabetes, in women, and in the elderly.

  • Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
    Federico Perez, MD and David Van Duin, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 225-233; DOI: https://doi.org/10.3949/ccjm.80a.12182

    The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.

  • Options for managing severe aortic stenosis: A case-based review
    Options for managing severe aortic stenosis: A case-based review
    Olcay Aksoy, MD, Bridget L. O’brien, MD, FACC and Venu Menon, MD, FACC, FAHA
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 243-252; DOI: https://doi.org/10.3949/ccjm.80a.12078

    Today, patients who cannot undergo surgery can be offered a variety of less invasive treatments. We use seven cases to illustrate how to manage these patients.

  • Frailty in older adults: Implications for end-of-life care
    Katalin Koller, MD, FRCP and Kenneth Rockwood, MD, FRCPC, FRCP
    Cleveland Clinic Journal of Medicine March 2013, 80 (3) 168-174; DOI: https://doi.org/10.3949/ccjm.80a.12100

    By recognizing and measuring frailty, clinicians can better engage patients and their loved ones in difficult discussions about prognoses and plans, and can ultimately give better palliative care.

  • Septic shock: The initial moments and beyond
    Simon W. Lam, PharmD, Seth R. Bauer, PharmD and Jorge A. Guzman, MD
    Cleveland Clinic Journal of Medicine March 2013, 80 (3) 175-184; DOI: https://doi.org/10.3949/ccjm.80a.12002

    Evidence-based protocols have improved the outcomes of septic shock. The authors review the evidence.

  • Cervical cancer screening: What’s new and what’s coming?
    Xian Wen Jin, MD, PhD, FACP, Laura Lipold, MD, Margaret McKenzie, MD and Andrea Sikon, MD, FACP
    Cleveland Clinic Journal of Medicine March 2013, 80 (3) 153-160; DOI: https://doi.org/10.3949/ccjm.80a.12092

    In their 2012 guidelines, several organizations call for less-frequent but more-effective screening that incorporates testing for human papillomavirus.

  • Fecal microbiota transplantation for recurrent <em>C difficile </em>infection: Ready for prime time?
    Fecal microbiota transplantation for recurrent C difficile infection: Ready for prime time?
    Markus D. Agito, MD, Ashish Atreja, MD, MPH, FACP and Maged K. Rizk, MD
    Cleveland Clinic Journal of Medicine February 2013, 80 (2) 101-108; DOI: https://doi.org/10.3949/ccjm.80a.12110

    If you had a serious disease, would you agree to an alternative treatment that is cheap, safe, and effective—but seems disgusting? Would you recommend it to patients?

Pages